Objectives: Antineoplastic drugs are widely used in anticancer therapy due to their cytotoxic activity but many of them are classified as carcinogenic, mutagenic, or teratogenic to humans. In order to evaluate personal exposure, surface monitoring has been successfully applied for several years. In this study, we present a statistical description of our data set from 102 German pharmacies and propose 'threshold guidance values (TGVs)' to facilitate interpretation of monitoring results.
INTRODUCTION
Antineoplastic drugs are widely used in anticancer therapy due to their cytotoxic activity. However, they are not only selective for cancer cells but also can affect the growth and reproduction of healthy cells. Some antineoplastic drugs are therefore classified as potentially carcinogenic, mutagenic, or teratogenic to humans (IARC, 1987 (IARC, , 1997 . Falck et al. (1979) first recognized the potential health hazard in occupational exposure describing mutagenic activity in the urine of nurses handling cyclophosphamide and other cytostatic drugs without protective measures. Also toxic effects on reproductive health of female nurses were reported (Stuecker et al., 1990; Saurel-Cubizolles et al., 1993; Valanis et al., 1997; Dranitsaris et al., 2005) .
Several biomonitoring studies demonstrated that nurses and pharmacy personnel involved in preparation or administration are exposed to antineoplastic drugs, detecting cytotoxic agents or their metabolites in urine and blood (Pethran et al., 2003; Turci et al., 2003; Fransman et al., 2007) . However, the path of incorporation remained largely unknown. Contact with contaminated surfaces seemed to play a role in dermal exposure to antineoplastic drugs (Hirst et al., 1984; Sessink et al., 1994; Kromhout et al., 2000; Fransman et al., 2005) . Therefore, subsequent studies focussed on environmental and surface monitoring in hospital facilities. Many of such 'wipe sample studies' demonstrated widespread workplace contamination, even though strict protocols and standard operating procedures were applied (Turci et al., 2003; Hedmer et al., 2005; Mason et al., 2005; Brouwers et al., 2007) .
In Germany and many other western European countries, the preparation of antineoplastic drugs is centralized in hospital and some retail pharmacies. In these settings, specific guidelines and protective measures are applied, such as biological safety cabinets (BSCs), in order to reduce exposure as much as possible. This is very important because at present it is impossible to set a no-effect level for exposure to cytotoxic drugs below which there is no risk of adverse health effects. Therefore, health-based threshold limit values or biological exposure indices for antineoplastic drugs in order to protect occupationally exposed personnel are not likely to be established in the near future.
In 2000, we introduced a validated wipe sampling method for monitoring surface contamination by antineoplastic drugs (Schmaus et al., 2002) . Up to now, we analysed .2200 samples from German hospital and retail pharmacies concerning platinum (PT) (as a marker for the cytostatic drugs cis-, carbo-, and oxaliplatin) and 5-fluorouracil (FU).
The aim of the present study was to develop and provide guidance values on the basis of new data from a comprehensive study in Germany evaluating contamination levels from different sites of cytostatic drug preparation. Such threshold guidance values (TGVs) could assess the effectiveness of preparation and protection procedures and to help the pharmacy personnel to benchmark their results and to improve their procedures. Thus, possible health risks at pharmacy workplaces should thereby be continuously reduced.
METHODS

Pharmacies
Our validated wipe sampling method was developed in cooperation with the German Berufsgenossenschaft für Gesundheitsdienst und Wohlfahrtspflege (BGW). This institution is the statutory accident insurer for non-governmental institutions in the health and welfare services in Germany. It is authorized to provide safety instructions and supports preventive measures. Since 2000, the BGW recommended our wipe sampling method to health care facilities in order to monitor working procedures and contamination levels. Up to now, 102 hospital and retail pharmacies participated with very different amounts of handled antineoplastic drugs from only a few preparations a week up to .100 per day. The high number of pharmacies represents the diversity of hospital and retail pharmacies in Germany in terms of size and amount of PT and 5-FU handled. Quantities of processed PT and 5-FU were available from 52 pharmacies. The median quantity handled per year was 14. . No data were available for oxaliplatin. The 75th percentile for cisplatin, carboplatin, and 5-FU was 42.0 g year
À1
, 119 g year
, and 4307 g year
, respectively. As reported in a former investigation, no significant correlation could be found between contamination levels and the amount of handled antineoplastic drugs (Heise, 2006) . This is also confirmed in a recent study from the German BGW (Heinemann et al., 2008) and in the study of Brouwers et al. (2007) . Therefore, no further information about the handled quantities of PT compounds and 5-FU was provided. Each pharmacy consisted of a preparation room with at least one hood and a room for storage and office purposes. Working and personal equipment as well as safety precautions are generally standardized in Germany. In general, various types of Class II BSCs were used. Working procedures as well as technical and personal equipment were evaluated and described in a former investigation (Heise, 2006) finding out that in detail personal protective equipment and handling practices differed widely and showed no crucial impact on environmental contamination levels, which was also reported in the study of the German BGW (Heinemann et al., 2008) . Therefore, detailed information about equipment was not collected in the present study.
Investigated antineoplastic agents
Because it is not possible to measure all different types of antineoplastic drugs, we used PT (marker of cis-, carbo-, and oxaliplatin) and 5-FU. Both are suitable indicators for occupational exposure to antineoplastic drugs owing to their frequent use in number of preparations and high amounts. Sensitive analytical methods are already established for them, which is very important in order to provide the required statistical evaluation.
Wipe sampling
For an effective and easy on-site wiping procedure, we developed a wiping kit (Funck and Schierl, 2004) , which includes all necessary tools, adapted to the monitored drugs, with detailed instructions and photos of sampling technique. Wipe sampling was carried out by local pharmacy personnel. One basic wiping procedure was utilized for PT and 5-FU according to Schmaus et al. (2002) . Three filters were used for each wipe sample. Before wiping, filters were slightly moistened each with eight drops of an appropriate solvent (0.03 N HCl for PT, methanol for 5-FU). Sampling was performed by consecutive wiping with three filters, each in a different direction, to cover an area of 20 Â 20 cm in general. However, for surfaces, for which this size was not practical, the sampled area was exactly recorded. Filters were stored in containers at 4°C and sent back to our laboratory overnight. Our recommended sampling areas Table 1 . Location 2 (floor in and outside) included floor surfaces inside the preparation room (except the area in front of the BSC) or inside the sluice room as well as floor surfaces in storage areas and anterooms or offices. The benchtop surfaces on which the drug vials and other materials were allocated are summarized under the item 'pre-preparation' (Location 4). Surfaces on which intravenous admixture containers and infusions were placed after preparation and before packing and delivering to the clients were entitled 'post-preparation' (Location 6). Location 10 (other surfaces) included different surfaces in the preparation room and in the anteroom (e.g. desk top, telephone, door knobs) except floors. The PactoSafe system (Location 7) is a waste handling system that encapsulates the antineoplastic contaminated waste into heat-sealed bags. According to the wiping instructions, samples should be taken from surfaces around the opening. Other waste bins comprised bins for residual and contaminated waste and were also summarized under Location 7 because of their small number (PT: n 5 2, 5-FU: n 5 11). Wipe samples from waste bins were taken from the lid. The transfer chamber is used for handing over the drugs for the daily preparation into the preparation area. Wipe samples from vials were excluded from this study and will be analysed separately.
Analytical procedures
PT and 5-FU analyses were performed as described in detail elsewhere (Schmaus et al., 2002) . Briefly, for PT analysis one millilitre of HCl solution was taken and after addition of H 2 O 2 and H 2 SO 4 , the organic compounds were digested by ultraviolet radiation. PT concentrations were determined by inverse voltammetry as previously described (Ensslin et al., 1994) .
The substance 5-FU was analysed by gas chromatography/mass spectrometry (GC/MS). Methanol was used as the organic solvent and 5-chlorouracil (ClU) as an internal standard. Derivatization was performed by N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide at 70°C. GC/MS was recorded in the selected ion mode with m/z 301 for FU and m/z 317 for ClU.
From all pharmacies, blank samples were determined for both agents. To test the recovery of the drugs, different amounts of each drug were placed on 20 Â 20 cm glass plates with a dropper. Six samples were applied for each drug concentration. The recovery rates ranged between 98 and 101% for PT and between 92 and 111% for 5-FU. The limits of detection (LOD) for PT and 5-FU were 0.01 ng per sample and 0.3 ng per sample, respectively. For the wiping area of 400 cm 2 , the detection limits were 0.025 pg cm À2 and 0.75 pg cm
À2
, respectively. PT is an element that appears in the environment not only due to contamination with PT-containing drugs but also due to emission by car exhaust catalysts. Because voltammetry only measures total PT, it is not possible to separate PT from antineoplastic drugs and from environmental sources. So it might be possible that road dust was transported to floors in pharmacies. But several tests showed that this impact is ,0.1 pg cm À2 which is in agreement with data shown by Brouwers et al. (2007) .
Statistical analysis
Statistical analyses were carried out using the software package SPSS 15.0 for Windows. The normality of the frequency distribution of the collected data (surface concentrations of PT and 5-FU) was evaluated by Kolmogorov-Smirnov tests. Since data were not normally distributed, the minimum, maximum, quartiles, and 90th percentiles are presented. For statistical calculations, values below the LOD were set as 1/2 LOD. For working out TGVs, the arithmetic mean values of 50th and 75th percentiles of all 10 locations were calculated because data were normally distributed.
RESULTS
In total, a number of 1008 wipe samples for PT and 1237 for 5-FU were taken from 102 German hospital and retail pharmacies (see Table 1 ). In all, 69.4% of pharmacies sampling PT and 57.1% of pharmacies sampling FU were hospital pharmacies. The median amount handled per year was 14.8 g year À1 cisplatin, 70.9 g year À1 carboplatin, and 2980 g year À1 5-FU and was evaluated from 52 of the 102 pharmacies. Altogether, 74.4% of the FU samples and 99.2% of the PT samples were above the LOD. Tables 2-3 show the number of wipe samples for each location, the contamination levels for the investigated agents, and the mean values of percentiles from all the locations.
On nearly all surfaces, contamination with PT could be found (Table 2) . Depending on sampling location, 97-100% of the PT samples showed measurable contamination. The surface load varied remarkably between the pharmacies and ranged from ,LOD up to 23 068 pg cm À2 . The highest PT contamination was detected on a storage shelf for PTcontaining vials before preparation. The columns for the 50th percentiles (50% of all samples are below/above) and the 75th percentiles (25% of all samples are above) are indicated by a frame because those are the basis of our TGV concept, which will be explained later. Considerable amounts of PT were found on surfaces inside the BSC and on surfaces where PT-containing vials were stored. Separate analysis of the wipe samples from the floor inside (n 5 99) the preparation room or sluice room and outside (n 5 24) the preparation room (e.g. storage area, office) showed no differences in resulting percentiles. The median contamination levels were 0.30 and 0.38 pg cm
À2
, respectively. The waste bins, in all but two cases a PactoSafe system, were considerably contaminated, but also the other locations showed measurable drug concentrations. The values of the 75th percentiles exceeded those of the 50th percentiles to a considerable degree. In particular, high increases of contamination from the 75th to the 90th percentile were found. The mean maximum values of all 10 locations were $1000-fold higher than those of the 75th percentiles.
The surface contamination by FU (Table 3 ) showed a similar contamination pattern to that of PT with high contamination on the worktop inside the hood and the surfaces in drug storage areas. About a quarter (n 5 317) of 1237 FU samples showed values below the LOD (0.75 pg cm
) and 74.4% of the FU samples had measurable contamination on all 10 locations. Again, the columns for the 50th percentiles (50% of all samples are below/above) and the 75th percentiles (25% of all samples are above) are indicated by a frame because those are the basis of our TGV concept. Most positive results for FU were found on the floor in front of the BSC (Location 1) and on the storage shelves (Location 3). Comparable to PT results, the FU concentration also ranged extremely wide from ,LOD up to 253 333 pg cm À2 . The highest FU level was detected in a transfer chamber where the drugs for daily preparation are handed over into the preparation area, but also the benchtops where vials were placed before preparation (Location 4) and the floors (Locations 1 and 2) were considerably contaminated. Separate analysis of the floor samples from Location 2 showed that the evaluated percentiles from inside the preparation room and the sluice room (n 5 99) were slightly higher (median: 5.00 pg cm À2 , 75th percentile: 17.50 pg cm À2 ) than from the floors like storage area or office outside the preparation room (n 5 37, median: 3.00 pg cm À2 , 75th percentile: 11.00 pg cm
). The median concentration on outside surfaces from PactoSafe waste bins was 5.25 pg cm À2 while other waste bins not explicitly claimed as PactoSafe system showed a median contamination of 2.50 pg cm À2 FU. Even surfaces such as door handles and keypads in administration areas (summarized under Location 10) showed remarkable FU loads. Three-to 10-fold increases of contamination from the 50th to the 75th percentiles and yet much higher increases to the 90th percentiles were obvious. The mean values of the percentiles of contamination levels from FU often were about 10 times higher than those of PT.
Contamination differed from pharmacy to pharmacy and also from sampling to sampling, regardless of hospital or retail pharmacy. As there are no real thresholds established for antineoplastic drugs, guidance values could help drug-manipulating personnel to assess occupational exposure. For easier categorization of the surface load with the antineoplastic drugs PT and FU, two guidance values for each agent, based on this large data basis would be helpful to classify wipe sampling results for occupational exposure (Table 4) . We developed a 'traffic-light' classification system which allows simple presentation of the results and easier evaluation for pharmacy personnel. The mean values of the 50th and the 75th percentiles of PT and FU were already presented in Tables 2 and 3 and were accounted as applicable TGVs (TGV 1 and TGV 2, respectively) for assessing contamination levels. For practical reasons, the mean values were rounded. The first TGV (TGV 1) was set at the mean of the 50th percentiles. Values below the TGV 1 implicate low contamination levels (green colour). The second guidance value (TGV 2) was set at the mean of the 75th percentiles to mark the boundary for higher contamination levels (red colour). Values between the first and second TGV were considered as yellow coloured.
In order to check if this concept would work, we evaluated our data set. Therefore, we evaluated pharmacies who did wipe sampling twice during recent years. Altogether, 39 pharmacies repeated collection of PT wipe samples and 35 pharmacies repeated collection of FU wipe samples at the same locations. Thereby, 167 wipe samples were taken each in Sampling 1 and Sampling 2 for PT and 234 samples per sampling for FU. Together with the report of the first sampling's results, the pharmacies received some recommendations like -attention on external vial contamination -possible contamination on storage surfaces -risk of contaminated disinfection solution dripping off from vials onto the floor -careful handling during preparation inside the BSC -careful disposal from waste -accurate cleaning procedures. Table 5 presents the number of samples for PT and FU which showed contaminations above the TGV 1 or above the TGV 2 in the first sampling, and the corresponding results in the second sampling period. Generally, the results of the second sampling showed less contamination compared to the first sampling period, but some were more contaminated. But even in cases where the second sampling was remaining in the 'red' group, lower contamination could be measured in most cases. Regarding PT, 92 of 167 samples from Sampling 1 were above the TGV 1 and 53 of these 92 samples (57.6%) were still above the TGV 1 in Sampling 2. But 82.6% (n 5 76) of the results improved with lower concentrations found in the second sampling. From 234 FU samples, 114 showed concentrations above the TGV 1 for FU. Although 64 FU samples of these 114 samples (56.1%) still showed values above the TGV 1 for FU in the second sampling, in 83.3% (n 5 95) of all results were lower in Sampling 2.
For PT, 89.4% of the samples exceeding the TGV 2 in the first sampling were less contaminated in Sampling 2, but 31.9% (n 5 15) of the cases still were above the TGV 2. From the 59 results in Sampling 1 higher than the TGV 2 for FU, 22 (37.3%) still exceeded the TGV 2 in the second sampling. Nevertheless, reduction of the FU levels from Guidance values for surface monitoring of antineoplastic drugs in German pharmacies 707
Sampling 1 to Sampling 2 took place in 91.5% of the samples (Table 5) .
DISCUSSION
In our study, we present a large database of current antineoplastic drug contamination levels in German pharmacies determined by wipe samples, providing a basis for proposing applicable TGVs for occupational hygiene. The applied environmental monitoring with wipe samples is in accordance with recent recommendations for benchmarking environmental cytotoxic contamination given by 'The United States Pharmacopeial Convention' (Pharmacopeia, 2008) . As there is no ability at present to set a threshold value based on the toxicity of PT and 5-FU in humans, the toxicological assessment of the results was not subject of the present study. Thus, we could give no risk assessment for the likelihood for adverse health effects. We rather provided a new practicable approach for establishing guidance values for classification of surface contamination loads and for optimiziation of individual working practice in German pharmacies with the aim to reduce workplace contamination with antineoplastic agents. As it is not realistic to monitor all cytotoxic drugs, we determined PT and FU levels as representative markers due to their frequent use in high amounts and due to established sensitive analytical methods. Although the selection of the pharmacies was not randomized, the 102 facilities are representative for German pharmacies in terms of size and amount of PT and FU compounds handled. The evaluation of processed drug quantities from 52 of the 102 pharmacies were not related to the contamination levels in pharmacy sites (Heise, 2006) , which is in accordance with other recently published studies (Brouwers et al., 2007; Heinemann et al., 2008) .
The contamination ranged considerably on all surfaces. PT and FU concentrations varied extremely between ,ND (not detected) to 23 068 pg cm À2 and ,ND to 253 333 pg cm À2 , respectively. The results reveal that on all 10 selected locations contamination could be demonstrated even if a substantial variation in surface contamination was noticed.
Nearly all (99.2%) PT samples were above the detection limit (0.025 pg cm
À2
). For FU, we found nearly 75% above the LOD, most likely due to the less sensitive LOD (0.75 pg cm À2 ). This complies with the study of Brouwers et al. (2007) , who detected PT in 94% of the results (88% . 0.100 pg cm À2 ), but is much higher than the number of positive FU results (8%) Harrison et al. (2006) reported. Castiglia et al. (2008) detected less FU contamination in antineoplastic drug processing wards, but if contamination was found, levels were up to 1000 times higher than our levels. This is most likely caused by less sensitive LODs of those investigations and also indicating exceedingly high occupational hygiene standards in German pharmacies.
For interpretation of the PT results, it is important to take into account that PT appears in the environment not only due to contamination with antineoplastic drugs but also due to emission by car exhaust catalysts. However, this has to be taken into account only for floors where contamination could occur from shoes distributing road dust inside the pharmacies. Levels of the magnitude of 0.1 pg cm À2 were generally far below our presented 25th percentiles and therefore of minor relevance. All surfaces in the pharmacies above this level could be considered as being contaminated by PT-containing drugs (Brouwers et al., 2007) .
In general, results show that the hoods, the floors, and the storage area as well as PactoSafes/waste bins, transport boxes, and transfer chambers were often contaminated both with PT and FU. For example, even 25% of the investigated surfaces in storage areas showed FU contamination levels of over 80 pg cm À2 (75th percentile) and even transport boxes and transfer chambers had values $20 pg cm À2 (75th percentile). This demonstrates that contamination was often spread throughout the pharmacy. As expected, higher loads of antineoplastic drugs were detected on surfaces inside the BSC (median for , respectively). A certain amount of spillage during preparation cannot be avoided, but considering the risk of spread, precise handling even inside the BSC is essential. High levels of FU and PT contamination inside the hood have been also reported in studies which performed wipe sampling on this location (Sessink et al., 1992; Connor et al., 1999; Floridia et al., 1999; Crauste-Manciet et al., 2005; Brouwers et al., 2007) . In particular, results reported in older studies showed ranges in higher magnitude of contamination levels compared to our findings pointing out the constant improvement in general and the currently high occupational hygiene standards in German pharmacies.
It is noteworthy that we also found considerable concentrations of PT and FU up to 253 000 pg cm À2 on surfaces which were not strictly related to the preparation of the drugs (e.g. post-preparation benchtop, storage shelves, transfer chambers, floors apart from the BSC). These results may be due to spillage within the preparation process as well as to inadequate cleaning procedures or incorrect working modalities. For example, we reported in an earlier study that disinfection solution dripping off the external contaminated vials could cause high contamination levels on the floor (Heise 2006) . No significant differences were found between contamination on the outside surfaces around the opening of the PactoSafe waste systems and other waste bins used to dispose of contaminated or residual waste. External vial contamination is previously reported (Delporte et al., 1999; Nygren et al., 2002; Favier et al., 2003; Mason et al., 2003; Hedmer et al., 2005) and seems to be a substantial factor for contamination on surfaces where vials were placed and handled. This could therefore be related to the high drug concentrations on storage shelves up to 72 000 pg cm À2 for FU and 23 000 pg cm À2 for PT, which were even exceeded by FU results reported by Floridia et al. (1999) . Contamination on the floor in front of the hood and on other floors (e.g. middle of the preparation room, outside the preparation room) can occur apart from spillage or distribution via shoes when disinfection solution drips off the contaminated vials. These levels on the floor were considerably lower than results from elder studies (Connor et al., 1999; Floridia et al., 1999; Micoli et al., 2001) , but agreed in the magnitude of levels from more recent publications (Ziegler et al., 2002; Mason et al., 2005; Brouwers et al., 2007) demonstrating high drug loads on pharmacy floors, too. This is probably due to the better occupational hygiene practice compared to earlier investigations.
As no occupational threshold limits for acceptable amount of contamination for cytotoxic drugs have been set so far, they should theoretically all be absent from all workplaces. As this is not realistic, introducing guidance values might be a helpful tool to classify wipe sampling results, but without evaluation of the toxicological risk. Guidance values are practicable, achievable levels, and not health based. Essential for calculating guidance values is a sufficient database of wipe samples produced with validated monitoring methods, collected in representative workplaces with good occupational hygiene practices, suitable for calculation of surface contamination with antineoplastic drugs (Cocker et al., 2007) . As these conditions are achieved for PT and FU in our study, we introduced a proposal for TGVs for German hospital and retail pharmacies. In the recent literature, some guidance values were already proposed for other substances or for biomonitoring results and were generally set at the 90th percentile (Cocker et al., 2007) . Even if predictions about health relevance are not possible, our results have shown that it is definitely possible to have only low or even no surface contamination. Obviously, the occupational hygiene standard in the investigated German pharmacies presented here is so high that we found it reasonable to set the threshold levels far lower in order to adapt them to this standard and to support further improvement. Therefore, we estimated the 50th and the 75th percentiles from all 10 locations as suitable limits for lower (TGV 1) and higher (TGV 2) contamination. Different guidance values were defined for PT and FU, because within 2245 analysed samples, the obtained concentrations were different for PT and for FU. We developed a traffic-light classification system to help the pharmacy personnel to benchmark their own results: 'Green' colour means contamination levels below the TGV 1 and implicates comparably good results. The colour 'yellow' refers to surface loads with levels between TGV 1 and TGV 2. 'Red colour' marks results above the TGV 2 with very high contamination levels and a need for improving working procedures. With this concept, pharmacies are able to compare their individual results to the TGVs representing the 50th and 75th percentiles of a large database and optimize their working procedures following the recommendations mentioned above.
To test our proposed TGV, we evaluated all pharmacies which did wipe sampling on the same locations at least twice in order to compare the results with regard to our proposed TGVs. When sending the results from the first sampling to the pharmacies, we provided an evaluation of their individual results and gave recommendations for reducing contaminations (e.g. external vial contamination on storage and pre-preparation surfaces, accuracy while disinfection and preparation in the hood). It is noteworthy that improvement of PT and FU contaminations from Sampling 1 to Sampling 2 took place in 82.6-91.5%. This is a very promising result, given that the classification system was not yet established at the moment Guidance values for surface monitoring of antineoplastic drugs in German pharmacies 709 when the wipe samplings were carried out. Benchmarking their contamination levels with the whole database could be a further stimulating factor for occupational hygiene improvement.
CONCLUSION
This study presents a large overview over current surface contamination levels with PT and 5-FU in German pharmacies and provides a database of 2245 values. We have demonstrated that particularly the hoods, the floors, and storage shelves were highly contaminated, but contamination was often spread throughout the pharmacy. Otherwise, it is also shown that very low surface loads with cytotoxic drugs are definitely possible. We proposed two TGVs both for PT and 5-fluororacil basing on the 50th and 75th percentiles of all results. The introduction of TGVs helps to reduce occupational exposure and allows pharmacy personnel to benchmark their own contamination levels. This provides a basis for improvement in occupational safety precautions and for regular contamination controls.
